| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated subsequent lung cancer after post-operative radiotherapy for breast cancer
|
Basse, Clémence
|
|
|
182 |
C |
p.
|
artikel
|
| 2 |
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer
|
Tsakonas, Georgios
|
|
|
182 |
C |
p.
|
artikel
|
| 3 |
Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer
|
Lin, Zeyun
|
|
|
182 |
C |
p.
|
artikel
|
| 4 |
Contents
|
|
|
|
182 |
C |
p.
|
artikel
|
| 5 |
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer
|
Dickhoff, C.
|
|
|
182 |
C |
p.
|
artikel
|
| 6 |
Magnetic resonance imaging for prospective assessment of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy
|
Kirshenboim, Zehavit
|
|
|
182 |
C |
p.
|
artikel
|
| 7 |
NSCLC presents metabolic heterogeneity, and there is still some leeway for EGF stimuli in EGFR-mutated NSCLC
|
Mendes, Cindy
|
|
|
182 |
C |
p.
|
artikel
|
| 8 |
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer
|
Bhalla, Sheena
|
|
|
182 |
C |
p.
|
artikel
|
| 9 |
Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)
|
Katakami, Nobuyuki
|
|
|
182 |
C |
p.
|
artikel
|
| 10 |
Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors
|
Heudel, P.E.
|
|
|
182 |
C |
p.
|
artikel
|
| 11 |
Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer
|
Donker, H.C.
|
|
|
182 |
C |
p.
|
artikel
|
| 12 |
Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis
|
Laeseke, Paul
|
|
|
182 |
C |
p.
|
artikel
|
| 13 |
Stereotactic Body Radiotherapy for Lung Oligo-metastases: Systematic Review and International Stereotactic Radiosurgery Society Practice Guidelines
|
Mayinger, Michael
|
|
|
182 |
C |
p.
|
artikel
|
| 14 |
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines
|
Yan, Michael
|
|
|
182 |
C |
p.
|
artikel
|
| 15 |
Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors
|
Swart, Esther M.
|
|
|
182 |
C |
p.
|
artikel
|
| 16 |
T cell immunity in interstitial lung disease with non-small cell lung cancer patients
|
Isono, Tomomi
|
|
|
182 |
C |
p.
|
artikel
|
| 17 |
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial
|
Levallet, Guénaëlle
|
|
|
182 |
C |
p.
|
artikel
|
| 18 |
ZLDI-8 suppresses angiogenesis and vasculogenic mimicry in drug-resistant NSCLC in vitro and in vivo
|
Lu, Hongyuan
|
|
|
182 |
C |
p.
|
artikel
|
Tijdschrift beschrijving